begin
fall
increas
alarm
number
case
calv
suffer
liver
dystrophi
report
south
germani
epidemiolog
investig
carri
author
novemb
juli
lead
implic
commerci
dietari
supplement
potenti
caus
outbreak
compon
product
first
test
cell
cultur
model
two
dietari
chestnut
extract
glycerol
monolaur
show
cytotox
effect
object
studi
therefor
evalu
effect
supplement
feed
compon
alon
combin
liver
function
newborn
calv
commerci
dairi
farm
ten
calv
enrol
three
treatment
group
control
group
group
follow
block
design
treatment
consist
supplement
chestnut
extract
birth
bodi
mass
bm
group
c
supplement
glycerol
monolaur
bm
group
g
combin
treatment
group
cg
five
consecut
day
effect
treatment
liver
function
evalu
clinic
measur
glutam
dehydrogenas
gldh
aspart
aminotransferas
ast
activ
well
determin
concentr
glucos
llactat
total
bilirubin
serum
signific
increas
gldh
ast
activ
signific
decreas
glucos
concentr
treatment
group
c
cg
compar
control
group
p
wherea
differ
shown
group
g
surviv
significantli
decreas
group
c
p
cg
p
compar
group
g
control
group
result
suggest
dietari
chestnut
extract
amount
bm
alon
combin
toxic
effect
liver
function
newborn
calv
unusu
high
number
case
jaundic
young
calv
report
southern
germani
begin
fall
result
epidemiolog
survey
carri
bavaria
novemb
juli
follow
preliminari
feed
trial
carri
author
suggest
causal
involv
commerci
avail
dietari
supplement
use
prevent
treatment
diarrhoea
neonat
calv
metzner
et
al
detail
inform
epidemiolog
investig
preliminari
feed
trial
dietari
supplement
found
elsewher
metzner
et
al
investig
acetonitrilewat
extract
compon
dietari
supplement
feed
mtt
assay
accord
reubel
et
al
reduct
yellow
tetrazolium
salt
violet
formazan
cellular
enzym
use
human
epidermoid
cancer
cell
reveal
cytotox
effect
two
test
compon
chestnut
extract
glycerol
monolaur
chestnut
extract
obtain
water
extract
chestnut
wood
castanea
sativa
mainli
compos
tannin
lignin
cellulos
hemicellulos
miner
salt
graziani
tosi
tannin
classifi
two
categori
hydrolys
nonhydrolys
condens
tannin
hydrolys
condens
tannin
exist
sweet
chestnut
wood
hydrolys
tannin
predomin
anad
et
al
use
antimicrobi
feed
addit
restrict
european
union
eu
altern
approach
sought
control
prevent
diseas
improv
growth
perform
farm
anim
interest
feed
ingredi
contain
tannin
increas
potenti
use
growth
promot
anim
feed
describ
literatur
hoog
et
al
antimicrobi
properti
graziani
tosi
tannin
result
benefici
effect
bodi
weight
gain
reduct
mortal
document
hoog
et
al
furthermor
tannin
suggest
good
candid
control
gastrointestin
parasit
rumin
min
et
al
broiler
chick
mccann
et
al
well
certain
avian
viru
infect
avian
reoviru
avian
metapneumoviru
lupini
et
al
paradox
tannin
produc
dosedepend
antinutrit
effect
time
fed
higher
dose
tannin
report
caus
growth
depress
reduct
feed
intak
digest
monogastr
mammal
smulikowska
et
al
rumin
mcsweeney
et
al
glycerol
monolaur
esterifi
form
lauric
acid
klevenhusen
et
al
natur
occur
monoglycerid
gener
recognis
safe
ingest
use
extens
food
industri
strandberg
et
al
recent
vitro
studi
document
effect
glycerol
monolaur
effect
growth
inhibitor
staphylococcu
aureu
kelsey
et
al
candida
speci
strandberg
et
al
virul
factor
produc
bacillu
anthraci
vetter
schlievert
recent
research
shown
feed
chestnut
extract
concentr
bodi
mass
improv
averag
daili
gain
feedlot
cattl
cervant
et
al
concentr
liu
et
al
neg
effect
liver
function
gener
condit
transit
dairi
cow
best
knowledg
howev
lack
inform
effect
chestnut
extract
well
glycerol
monolaur
liver
function
newborn
nonrumin
calv
object
studi
investig
whether
feed
either
one
combin
compon
identifi
cytotox
mtt
assay
chestnut
extract
glycerol
monolaur
concentr
correspond
commerci
product
describ
metzner
et
al
would
provok
liver
diseas
calv
control
clinic
trial
conduct
month
march
april
commerci
dairi
farm
milk
cow
southwest
bavaria
calv
born
heifer
cow
month
march
elig
enrol
total
newborn
calv
holstein
friesian
femal
two
brown
swiss
femal
eight
crossbr
calv
holstein
friesian
belgian
blue
four
male
four
femal
separ
dam
immedi
birth
weigh
move
individu
calf
hutch
flixbox
calf
igloo
mayer
traunstein
germani
concret
floor
straw
bed
first
colostrum
intak
h
birth
day
calv
receiv
three
litr
raw
colostrum
dam
follow
whole
milk
amount
birth
bodi
mass
bm
divid
three
daili
feed
pm
offer
nippl
bucket
order
enrol
control
three
treatment
group
well
alloc
first
calf
determin
random
enrol
thereaft
sequenti
block
four
calv
group
treatment
consist
supplement
daili
ration
chestnut
extract
alc
srl
bagni
di
lucca
itali
lot
bm
group
c
n
supplement
glycerol
monolaur
basf
monheim
germani
batch
bm
group
g
n
supplement
chestnut
extract
bm
plu
glycerol
monolaur
bm
group
cg
n
wherea
calv
group
receiv
supplement
serv
control
n
calcul
daili
amount
supplement
divid
three
equal
amount
mix
milk
immedi
feed
supplement
fed
total
day
day
calv
observ
period
day
sampl
size
determin
base
follow
assumpt
preliminari
feed
trial
metzner
et
al
liver
diseas
could
observ
four
four
experiment
calv
feed
dietari
supplement
feed
object
studi
investig
whether
liver
diseas
could
caus
feed
one
two
compon
alon
chestnut
extract
glycerol
monolaur
combin
null
hypothesi
defin
treatment
unabl
caus
liver
diseas
singli
combin
sampl
size
determin
base
power
signific
level
subsequ
adjust
familywis
error
rate
bonferroni
correct
assum
diseas
would
caus
least
calv
compon
causal
result
number
ten
calv
per
group
inflat
factor
assum
attrit
rate
anim
refus
supplement
milk
three
consecut
feed
exclud
studi
data
censor
daili
clinic
examin
use
standardis
score
sheet
carri
morn
feed
train
veterinarian
blind
treatment
group
paramet
evalu
score
system
includ
suckl
reflex
behaviour
postur
degre
dehydr
central
nervou
system
tabl
discolour
sclera
oral
mucosa
consist
faec
record
decreas
suckl
reflex
abnorm
behaviour
defin
score
higher
wherea
abnorm
postur
well
dehydr
defin
score
score
higher
regard
examin
nervou
system
consid
abnorm
rectal
temperatur
measur
time
everi
day
digit
thermomet
calv
treat
antiinfect
marbofloxacin
mgkg
bm
total
day
antiinflammatori
flunixin
meglumin
mgkg
bm
total
day
drug
case
omphal
bronchopneumonia
diagnos
investi
weak
intermitt
absent
chew
movement
behaviour
adequ
reaction
acoust
optic
stimuli
bright
alert
slightli
delay
reaction
acoust
optic
stimuli
alert
delay
reaction
acoust
optic
stimuli
dull
delay
reaction
acoust
optic
stimuli
apathet
calf
react
pain
stimuli
reaction
pain
stimuli
postur
upright
postur
straight
back
upright
head
carriag
normal
posit
ear
straight
back
line
upright
head
carriag
slight
droop
ear
arch
back
lower
head
droop
ear
stand
unsteadili
lift
arch
back
lower
head
droop
ear
sternal
recumb
lower
head
droop
ear
unabl
stand
later
recumb
degre
dehydr
normal
skin
tent
space
eyelid
eyebal
decreas
skin
tent
space
eyelid
eyebal
decreas
skin
tent
small
gap
mm
eyelid
eyebal
decreas
skin
tent
moder
gap
mm
eyelid
eyebal
decreas
skin
tent
larg
gap
mm
eyelid
eyebal
central
nervou
symptom
none
partial
seizur
tenesmu
generalis
tonicclon
seizur
bawl
vehement
tenesmu
opisthotonu
journal
anim
physiolog
anim
nutrit
blackwel
verlag
gmbh
gator
case
diarrhoea
faecal
consist
score
soupyrunni
standardis
oral
rehydr
solut
given
intraven
iv
fluid
contain
l
sodium
chlorid
solut
administ
case
sever
dehydr
describ
prospect
studi
niethamm
iv
fluid
contain
sodium
bicarbon
administ
accord
guidelin
describ
lorenz
lorch
calv
euthanis
either
suffer
sever
disturb
gener
condit
point
score
sheet
lack
respons
treatment
within
h
maximum
score
point
time
calv
die
euthanis
studi
period
submit
postmortem
examin
bavarian
health
food
safeti
author
oberschleissheim
surviv
male
calv
sold
week
end
studi
period
wherea
femal
calv
kept
farm
rais
replac
blood
sampl
collect
daili
immedi
morn
feed
jugular
vein
venipunctur
mm
needl
day
place
directli
smonovett
tube
sarstedt
umbrechtrommelsdorf
germani
blood
sampl
centrifug
within
h
sampl
g
min
serum
store
analysi
paramet
includ
glutam
dehydrogenas
gldh
ul
aspart
aminotransferas
ast
ul
glucos
mm
llactat
mm
total
bilirubin
lm
determin
use
automat
analys
system
automat
analyz
hitachi
roch
diagnost
indianapoli
usa
faecal
sampl
calv
collect
day
day
directli
rectum
anim
clean
glove
kept
refriger
faec
transport
cool
laboratori
compar
tropic
medicin
parasitolog
univers
munich
germani
process
within
day
collect
sampl
screen
presenc
cryptosporidium
speci
escherichia
coli
rotaand
coronaviru
use
enzymelink
immunoassay
bio
k
digest
kit
biox
diagnost
jemel
belgium
observ
intervent
carri
investig
accord
studi
guidelin
approv
start
trial
region
govern
upper
bavaria
germani
ref
data
analys
use
spss
version
ibm
spss
statist
armonk
ny
usa
assumpt
normal
met
nonparametr
test
appli
differ
four
group
assess
use
kruskalw
test
mannwhitney
utest
use
comparison
blood
valu
group
use
bonferroni
correct
comparison
cumul
surviv
three
treatment
group
control
group
logrank
test
use
calv
remain
studi
averag
day
baselin
characterist
calv
depict
tabl
day
trial
one
calf
group
c
anoth
calf
group
cg
die
peracut
anoth
three
calv
group
c
well
four
calv
group
cg
euthanis
accord
guidelin
figur
display
surviv
curv
treatment
control
calv
day
three
calv
group
cg
exclud
studi
data
censor
refus
supplement
milk
three
consecut
feed
surviv
differ
group
c
p
well
group
cg
p
depict
fig
activ
gldh
significantli
higher
group
c
day
well
group
cg
day
compar
control
group
p
ast
activ
significantli
higher
control
calv
day
group
c
p
day
group
cg
p
fig
increas
concentr
total
bilirubin
day
four
group
fig
day
concentr
total
bilirubin
significantli
p
higher
group
c
compar
group
comparison
group
cg
control
group
reveal
statist
signific
differ
concentr
total
bilirubin
time
howev
moder
increas
group
cg
day
glucos
concentr
significantli
lower
group
c
day
p
well
day
group
cg
p
compar
control
group
fig
signific
differ
gldh
ast
activ
total
bilirubin
glucos
concentr
detect
point
group
g
control
group
fig
median
llactat
concentr
four
group
respect
refer
rang
mm
major
sampl
day
fig
signific
differ
concentr
llactat
day
three
treatment
group
control
group
p
well
group
c
day
p
abnorm
postur
score
tabl
record
three
group
c
two
group
cg
four
case
group
g
across
day
trial
wherea
later
recumb
score
tabl
detect
three
anim
group
c
anoth
four
calv
group
cg
day
abnorm
behaviour
detect
two
calv
group
c
anoth
five
calv
group
cg
day
involv
central
nervou
system
day
document
two
calv
group
c
anoth
three
calv
group
cg
dehydr
record
one
calf
group
c
anoth
two
calv
group
cg
day
trial
decreas
suckl
reflex
observ
ten
case
group
c
nine
calv
group
cg
anoth
two
calv
group
g
day
trial
day
sever
hypothermia
rectal
temperatur
record
three
calv
fig
surviv
curv
demonstr
statist
signific
treatment
group
control
group
pvalu
display
respect
surviv
curv
censor
day
due
withdraw
three
calv
group
cg
fig
median
gldh
ul
calv
fed
five
consecut
day
chestnut
extract
group
c
chestnut
extract
plu
glycerol
monolaur
group
cg
glycerol
monolaur
group
g
control
calv
group
statist
signific
differ
group
c
indic
group
cg
fig
median
ast
ul
calv
fed
five
consecut
day
chestnut
extract
group
c
chestnut
extract
plu
glycerol
monolaur
group
cg
glycerol
monolaur
group
g
control
calv
group
statist
signific
differ
group
c
indic
group
cg
fig
median
total
bilirubin
lm
calv
fed
five
consecut
day
chestnut
extract
group
c
chestnut
extract
plu
glycerol
monolaur
group
cg
glycerol
monolaur
group
g
control
calv
group
statist
signific
differ
group
c
indic
fig
median
glucos
concentr
mm
calv
fed
five
consecut
day
chestnut
extract
group
c
chestnut
extract
plu
glycerol
monolaur
group
cg
glycerol
monolaur
group
g
control
calv
group
statist
signific
differ
group
c
indic
group
cg
group
c
five
calv
group
cg
anoth
two
calv
group
g
four
calv
group
c
two
calv
group
g
anoth
calf
group
rectal
temperatur
exceed
three
case
two
calv
group
c
anoth
calf
group
fever
detect
concurr
pneumonia
omphal
omphal
diagnos
two
calv
group
c
anoth
calf
group
cg
g
pneumonia
record
two
calv
group
c
one
calf
group
cg
g
none
calv
show
obviou
yellow
discolour
mucosa
dark
grey
discolour
gingiva
around
incisor
day
record
seven
calv
group
c
anoth
six
calv
group
cg
wherea
alter
kind
detect
calf
group
g
faec
reddish
brown
calv
group
c
cg
day
day
wherea
discolour
detect
calf
group
g
calv
suffer
diarrhoea
day
averag
day
tabl
list
result
investig
faecal
sampl
nine
calv
four
calv
group
c
anoth
five
calv
group
cg
necropsi
bavarian
health
food
safeti
author
organ
show
obviou
macroscop
chang
examin
histopatholog
find
calv
group
c
compris
singlecel
necrosi
mild
multifoc
periacinar
fatti
liver
cell
degener
n
moder
fatti
liver
cell
degener
periport
mononuclear
infiltr
n
sever
liver
cell
necrosi
n
combin
prolifer
bile
duct
epitheli
cell
periport
zone
one
case
group
cg
chang
liver
vari
singlecel
necrosi
mild
multifoc
periacinar
fatti
liver
cell
degener
n
sever
liver
cell
necrosi
n
combin
prolifer
bile
duct
epitheli
cell
periport
zone
macroscop
find
includ
seven
case
catarrh
enter
group
cg
n
group
c
n
volvulu
small
intestin
partial
caecal
necrosi
one
calf
group
cg
case
enter
five
test
posit
rotaviru
andor
cryptosporidium
parvum
one
case
bovin
viral
diarrhoea
viru
furthermor
presenc
sever
abomas
ulcer
document
one
calf
group
cg
fig
median
llactat
concentr
mm
calv
fed
five
consecut
day
chestnut
extract
group
c
chestnut
extract
plu
glycerol
monolaur
group
cg
glycerol
monolaur
group
g
control
calv
group
statist
signific
differ
group
c
indic
group
cg
group
g
tabl
result
faecal
examin
experiment
calv
day
use
enzymelink
immunoassay
bio
k
digest
kit
biox
diagnost
group
c
n
cg
n
g
n
n
aim
studi
investig
influenc
dietari
chestnut
extract
glycerol
monolaur
liver
function
newborn
calv
basi
clinic
laboratori
find
gldh
consid
liverspecif
enzym
effect
biomark
acut
hepat
injuri
activ
hepatocyt
ten
time
higher
tissu
releas
case
hepatocellular
necrosi
thoma
therefor
great
valu
indic
liver
diseas
adult
cattl
well
liver
dystrophi
calv
hunter
et
al
signific
increas
serum
gldh
activ
calv
group
c
cg
indic
acut
hepat
injuri
despit
fact
elev
ast
may
due
condit
involv
liver
consid
sensit
biomark
liver
cell
injuri
cattl
sattler
fuerll
signific
differ
activ
ast
group
c
day
well
group
cg
day
indic
hepatocellular
damag
two
treatment
group
includ
feed
chestnut
extract
although
total
serum
bilirubin
consid
sensit
indic
hepat
dysfunct
pratt
kaplan
elev
total
bilirubin
concentr
frequent
document
case
hepatocellular
necrosi
cattl
raposo
et
al
henc
signific
increas
concentr
total
bilirubin
group
c
day
indic
liver
dysfunct
support
evid
chestnut
extract
alon
combin
might
causal
factor
elev
concentr
llactat
within
first
h
life
follow
decreas
shown
fig
document
cattl
sever
author
egli
blum
accord
steinhardt
et
al
elev
llactat
concentr
consequ
increas
product
due
hypoxia
enhanc
sympathet
activ
due
stress
around
time
birth
importantli
elev
concentr
llactat
known
result
inhibit
mitochondri
function
certain
drug
impair
betaoxid
respiratori
chain
enzym
hallmark
mitochondri
impair
scatena
et
al
hepatocellular
dysfunct
pratt
kaplan
elev
concentr
llactat
also
seen
sever
dehydr
calv
suffer
acut
diarrhoea
tennant
et
al
determin
certainti
whether
increas
concentr
llactat
treatment
group
c
cg
direct
consequ
hepat
failur
due
dehydr
consequ
acut
diarrhoea
howev
three
calv
sever
dehydr
seem
like
substanti
increas
concentr
llactat
group
c
cg
direct
consequ
hepatocellular
dysfunct
neonat
diarrhoea
lead
abnorm
postur
behaviour
calv
sever
case
may
due
septicaemia
fecteau
et
al
dlactataemia
lorenz
howev
similar
abnorm
also
document
case
hepat
encephalopathi
buczinski
et
al
calv
studi
suffer
diarrhoea
extent
caus
abnorm
postur
behaviour
score
determin
abnorm
central
nervou
system
calv
due
hypoglycaemia
leifer
peterson
well
hepat
failur
among
reason
mayhew
sever
author
highlight
effect
low
ambient
temperatur
result
hypothermia
glucos
level
newborn
calv
diesch
et
al
temperatur
studi
period
rang
lower
temperatur
possibl
result
excess
cold
stress
rapid
deplet
carbohydr
reserv
todd
et
al
hypoglycaemia
depict
fig
calv
group
c
cg
may
due
loss
hepat
mass
consecut
failur
gluconeogenesi
scatena
et
al
dark
grey
discolour
gingiva
around
incisor
well
reddish
brown
discolour
manur
probabl
direct
effect
colour
properti
chestnut
extract
describ
liukkonenanttila
et
al
determin
studi
extent
depress
suckl
reflex
due
dlactataemia
lorenz
due
hepat
dysfunct
although
decreas
suckl
reflex
could
due
diarrhoea
associ
dlactataemia
specul
hepat
failur
major
caus
disturb
gener
condit
two
calv
group
c
five
calv
group
cg
score
respect
even
though
clinic
examin
carri
accord
standardis
protocol
lack
blind
might
led
introduct
undetermin
degre
observ
bia
signific
increas
gldh
ast
activ
total
bilirubin
concentr
well
signific
decreas
glucos
concentr
group
c
cg
compar
group
indic
hepatotox
effect
chestnut
extract
combin
chestnut
extract
glycerol
monolaur
contrast
chang
paramet
could
seen
feed
glycerol
monolaur
alon
consid
chemic
composit
chestnut
extract
hepatotox
effect
like
due
high
content
tannin
albeit
toxic
principl
tannin
fulli
ascertain
radostit
et
al
toxic
effect
associ
tannin
differ
speci
monogastr
anim
predominantli
develop
liver
gastrointestin
lesion
zhu
et
al
wherea
rumin
renal
damag
predomin
zhu
et
al
confirm
studi
may
due
function
monogastr
statu
newborn
calv
consecut
absenc
transform
tannin
rumen
lack
nephrotox
metabolit
zhu
et
al
clinic
cours
sever
diseas
well
mortal
studi
unexpect
experiment
calv
preliminari
feed
trial
show
less
pronounc
abnorm
metzner
et
al
yet
find
studi
strikingli
similar
descript
find
calv
describ
preced
epidemiolog
investig
commerci
dairi
farm
carri
novemb
juli
sever
caus
discuss
tri
explain
differ
feed
trial
contrast
preliminari
feed
trial
hospit
condit
present
studi
carri
field
condit
commerci
dairi
farm
assum
differ
due
locat
manag
pathogen
load
play
substanti
role
consist
condit
describ
preliminari
studi
despit
fact
calf
receiv
chestnut
extract
accord
individu
bodi
weight
calv
recov
clinic
diseas
affect
subclin
show
abnorm
blood
paramet
other
die
euthanis
concurr
infect
diarrhoea
pneumonia
etc
could
influenc
develop
sever
diseas
caus
treatment
mention
none
experiment
calv
preliminari
feed
trial
suffer
diarrhoea
wherea
present
studi
experiment
calv
extent
day
trial
apart
temperatur
preliminari
trial
may
june
therefor
decreas
risk
hypothermia
newborn
strike
differ
concern
clinic
outcom
present
studi
comparison
experiment
calv
preliminari
feed
trial
report
metzner
et
al
may
also
due
fact
feed
singl
compon
chestnut
extract
two
compon
chestnut
extract
plu
glycerol
monolaur
stronger
impact
liver
function
compar
feed
complet
feed
supplement
rule
hepatotox
effect
chestnut
extract
shown
studi
attenu
one
compon
commerci
product
question
whether
potenti
hepatotox
effect
compon
fed
time
could
fulli
resolv
due
unexpectedli
high
mortal
lead
prematur
termin
enrol
accord
stop
guidelin
defin
prior
start
studi
conclus
supplement
chestnut
extract
bm
combin
chestnut
extract
bm
glycerol
monolaur
bm
major
impact
liver
function
newborn
calv
investig
carri
investig
toxic
principl
predispos
factor
lead
harm
effect
chestnut
extract
alon
combin
supplement
consid
safe
feed
ingredi
newborn
calv
evalu
possibl
benefici
effect
proceed
guarante
